New Delhi, May 11 -- The Neurobiochemistry Laboratory at the Neurosciences Centre (NSC), All India Institute of Medical Sciences (AIIMS), has launched specialised Therapeutic Drug Monitoring (TDM) services for the antiepileptic drugs Levetiracetam and Lamotrigine for both OPD and IPD patients.

The introduction of these advanced diagnostic services marks a significant step toward strengthening precision-based epilepsy care and improving access to affordable, high-quality neurodiagnostic services for patients across the country.

The TDM facility has been established to support clinicians in optimising antiepileptic therapy through accurate monitoring of therapeutic drug levels, individualised dose adjustment, assessment of treatment respo...